Log in
Enquire now
‌

US Patent 11944612 Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

Patent 11944612 was granted and assigned to Global Blood Therapeutics on April, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Global Blood Therapeutics
Global Blood Therapeutics
0
Current Assignee
Global Blood Therapeutics
Global Blood Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119446120
Patent Inventor Names
Athiwat Hutchaleelaha0
Joshua Eli Lehrer-Graiwer0
Naveen Bejugam0
Eleanor L. Ramos0
Date of Patent
April 2, 2024
0
Patent Application Number
178818740
Date Filed
August 5, 2022
0
Patent Citations
‌
US Patent 9012450 Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
0
‌
US Patent 9018210 Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
0
‌
US Patent 9150569 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine
0
‌
US Patent 9248199 1:1 adducts of sickle hemoglobin
0
‌
US Patent 9422279 Compounds and uses thereof for the modulation of hemoglobin
0
‌
US Patent 9447071 Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
0
‌
US Patent 9458139 Compounds and uses thereof for the modulation of hemoglobin
0
‌
US Patent 9604999 Compounds and uses thereof for the modulation of hemoglobin
0
...
Patent Primary Examiner
‌
Jean P Cornet
0
CPC Code
‌
A61K 9/4858
0
‌
A61P 35/02
0
‌
A61K 31/4439
0
‌
A61K 9/1605
0
‌
A61K 9/4866
0
Patent abstract

Provided herein are methods for treating sickle cell disease, comprising administering to a subject 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)-methoxy)benzaldehyde (Compound 1), or a polymorph thereof, in certain dosing regimens.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11944612 Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.